Avighna Medicare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 200.15%
- Profit Growth -1339.00%
- Ebitda -109.43%
- Net Worth -1826.79%
- Total Assets 141.09%
About Avighna Medicare
Avighna Medicare Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 October 2018 (Six years and three months 7 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sagar Salvi, Dhiraj Jain, and Vaibhav Parekh serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2018PTC402763
-
Company No.
179888
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Oct 2018
-
Date of AGM
29 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Avighna Medicare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Salvi
|
Director | 05-Jul-2024 | Current |
|
Dhiraj Jain
|
Director | 16-May-2024 | Current |
| Vaibhav Parekh | Director | 22-Aug-2024 | Current |
Financial Performance of Avighna Medicare.
Avighna Medicare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 200.15% increase. The company also saw a substantial fall in profitability, with a 1339% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1826.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avighna Medicare?
In 2023, Avighna Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Akna Medical Private LimitedDhiraj Jain is a mutual person
-
Threpsi Solutions Private LimitedDhiraj Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avighna Medicare?
Avighna Medicare has a workforce of 32 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avighna Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avighna Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
